Literature DB >> 27888332

Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Alexander Khoruts1,2, Michael J Sadowsky1,3, Christopher Staley1, Alexa R Weingarden1.   

Abstract

Primary bile acids serve important roles in cholesterol metabolism, lipid digestion, host-microbe interactions, and regulatory pathways in the human host. While most bile acids are reabsorbed and recycled via enterohepatic cycling, ∼5% serve as substrates for bacterial biotransformation in the colon. Enzymes involved in various transformations have been characterized from cultured gut bacteria and reveal taxa-specific distribution. More recently, bioinformatic approaches have revealed greater diversity in isoforms of these enzymes, and the microbial species in which they are found. Thus, the functional roles played by the bile acid-transforming gut microbiota and the distribution of resulting secondary bile acids, in the bile acid pool, may be profoundly affected by microbial community structure and function. Bile acids and the composition of the bile acid pool have historically been hypothesized to be associated with several disease states, including recurrent Clostridium difficile infection, inflammatory bowel diseases, metabolic syndrome, and several cancers. Recently, however, emphasis has been placed on how microbial communities in the dysbiotic gut may alter the bile acid pool to potentially cause or mitigate disease onset. This review highlights the current understanding of the interactions between the gut microbial community, bile acid biotransformation, and disease states, and addresses future directions to better understand these complex associations.

Entities:  

Keywords:  Bile acids; C. difficile; Dysbiosis; Host-interactions; Microbial metabolism

Mesh:

Substances:

Year:  2016        PMID: 27888332      PMCID: PMC5203956          DOI: 10.1007/s00253-016-8006-6

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  187 in total

1.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Authors:  K B M Saiful Islam; Satoru Fukiya; Masahito Hagio; Nobuyuki Fujii; Satoshi Ishizuka; Tadasuke Ooka; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Yokota
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

Review 2.  The interaction between bacteria and bile.

Authors:  Máire Begley; Cormac G M Gahan; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2005-09       Impact factor: 16.408

3.  Cloning, sequencing, and expression of the gene coding for bile acid 7 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708.

Authors:  S F Baron; C V Franklund; P B Hylemon
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

4.  Fecal transplantation therapy for Clostridium difficile-associated pouchitis.

Authors:  Lisa N Patel; Jason Schairer; Bo Shen
Journal:  Int J Colorectal Dis       Date:  2013-10-17       Impact factor: 2.571

5.  Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.

Authors:  Stefan Bilz; Varman Samuel; Katsutaro Morino; David Savage; Cheol Soo Choi; Gerald I Shulman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-15       Impact factor: 4.310

6.  Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Authors:  David S Alberts; María Elena Martínez; Lisa M Hess; Janine G Einspahr; Sylvan B Green; A K Bhattacharyya; Jose Guillen; Mary Krutzsch; Ashok K Batta; Gerald Salen; Liane Fales; Kris Koonce; Dianne Parish; Mary Clouser; Denise Roe; Peter Lance
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

7.  LUV's lipid composition modulates diffusion of bile acids.

Authors:  M Hofmann; C Schumann; G Zimmer; K Henzel; U Locher; U Leuschner
Journal:  Chem Phys Lipids       Date:  2001-04       Impact factor: 3.329

8.  NADP-dependent 3 beta-, 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from a lecithinase-lipase-negative Clostridium species 25.11.c.

Authors:  R Edenharder; M Pfützner; R Hammann
Journal:  Biochim Biophys Acta       Date:  1989-03-14

Review 9.  Primary sclerosing cholangitis.

Authors:  Gideon M Hirschfield; Tom H Karlsen; Keith D Lindor; David H Adams
Journal:  Lancet       Date:  2013-06-28       Impact factor: 79.321

10.  Characterization of NAD-dependent 3 alpha- and 3 beta-hydroxysteroid dehydrogenase and of NADP-dependent 7 beta-hydroxysteroid dehydrogenase from Peptostreptococcus productus.

Authors:  R Edenharder; A Pfützner; R Hammann
Journal:  Biochim Biophys Acta       Date:  1989-08-08
View more
  144 in total

1.  Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.

Authors:  Denise M Ney; Sangita G Murali; Bridget M Stroup; Nivedita Nair; Emily A Sawin; Fran Rohr; Harvey L Levy
Journal:  Mol Genet Metab       Date:  2017-04-06       Impact factor: 4.797

Review 2.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

Review 3.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

4.  Phylogeny-corrected identification of microbial gene families relevant to human gut colonization.

Authors:  Patrick H Bradley; Stephen Nayfach; Katherine S Pollard
Journal:  PLoS Comput Biol       Date:  2018-08-09       Impact factor: 4.475

5.  Magnesium lithospermate B improves the gut microbiome and bile acid metabolic profiles in a mouse model of diabetic nephropathy.

Authors:  Jing Zhao; Qing-Li Zhang; Jian-Hua Shen; Kai Wang; Jia Liu
Journal:  Acta Pharmacol Sin       Date:  2018-06-25       Impact factor: 6.150

Review 6.  The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Authors:  Samantha N Freedman; Shailesh K Shahi; Ashutosh K Mangalam
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

7.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

8.  Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.

Authors:  Michael Camilleri
Journal:  J Crohns Colitis       Date:  2020-08-31       Impact factor: 9.071

Review 9.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

10.  Beyond the antibodies: serum metabolomic profiling of myasthenia gravis.

Authors:  Derrick Blackmore; Zaeem Siddiqi; Liang Li; Nan Wang; Walter Maksymowych
Journal:  Metabolomics       Date:  2019-08-01       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.